Maternal-Fetal Risk and Response: Optimizing Identification and Management of aHUS in Pregnancy and Postpartum - CME - Guideline Central

CME

Title
Maternal-Fetal Risk and Response: Optimizing Identification and Management of aHUS in Pregnancy and Postpartum
Link
Description
When atypical hemolytic uremic syndrome (aHUS) strikes during pregnancy or postpartum, every moment and decision matters. Yet, its overlap with other thrombotic microangiopathies makes accurate diagnosis a real clinical challenge. In this case-based podcast series, you’ll break down the role of complement dysregulation and how it contributes to adverse maternal outcomes. Learn how to distinguish aHUS from lookalike conditions, apply diagnostic criteria with confidence, and act quickly with appropriate treatment strategies. Expert insights and real-world scenarios highlight how multidisciplinary coordination can change the trajectory for both mother and child. If you manage complex pregnancies, this is the knowledge you can’t afford to miss.
Target Audience
This activity is designed to meet the educational needs of obstetricians, perinatologists (maternal-fetal medicine), and other subspecialists and care teams involved in the management of aHUS
Learning Objectives
  • Analyze the mechanisms of complement dysregulation in aHUS and relate them to adverse pregnancy outcomes
  • Apply diagnostic criteria to differentiate aHUS from other pregnancy-related thrombotic microangiopathies
  • Evaluate therapeutic strategies for managing aHUS in pregnancy and postpartum
  • Propose a multidisciplinary care model for aHUS in pregnancy and postpartum
Estimated Duration
60 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Psychiatry, Pediatrics, Obstetrics and Gynecology, Nephrology, Primary Care
Keywords
postpartum, pregnancy
Disclosures and Disclaimers
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Accredited Providers
  • The France Foundation
  • American College of Osteopathic Obstetricians and Gynecologists
Commercial Support
  • Alexion Pharmaceuticals, Inc
Activity Expiration Date
April 27, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.